These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22028264)

  • 21. [Ultrafiltration in heart failure].
    Antoniotti R; Antonucci E; Cremaschi E; Regolisti G; Cabassi A; Fiaccadori E
    G Ital Nefrol; 2012; 29(5):548-62. PubMed ID: 23117736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of peritoneal ultrafiltration in the elderly refractory congestive heart failure patients.
    Ruhi Ç; Koçak H; Yavuz A; Süleymanlar G; Ersoy FF
    Int Urol Nephrol; 2012 Jun; 44(3):963-9. PubMed ID: 22388751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug therapy of chronic heart failure].
    Watzinger N; Fruhwald FM; Klein W
    Wien Med Wochenschr; 1998; 148(5):128-30, 132-3. PubMed ID: 9654699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of ultrafiltration in refractory cardiac decompensation].
    Sagliaschi G; Persichetti S; Clemenzia G; Cottone G; Gallo G; Maggi S; Ponzio R; Punzo G; Spinelli C; Tozzo C
    Minerva Med; 1992 Oct; 83(10):637-40. PubMed ID: 1461535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases.
    Rubin J; Ball R
    Arch Intern Med; 1986 Aug; 146(8):1533-5. PubMed ID: 3729632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Refractory heart failure. Models of hospital, ambulatory, and home management].
    Oliva F; Alunni G
    Ital Heart J Suppl; 2002 Aug; 3(8):837-50. PubMed ID: 12407839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of heart failure and ascites with ultrafiltration in patients with intractable alcoholic cardiomyopathy.
    Bilora F; Petrobelli F; Boccioletti V; Pomerri F
    Panminerva Med; 2002 Mar; 44(1):23-5. PubMed ID: 11887087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrafiltration for congestive heart failure.
    Thorsgard M; Bart BA
    Congest Heart Fail; 2009; 15(3):136-43. PubMed ID: 19522963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal ultrafiltration in end-stage congestive heart failure.
    Wojtaszek E; Małyszko J; Matuszkiewicz-Rowińska J
    Cardiol J; 2014; 21(2):115-20. PubMed ID: 24526501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.
    Hashimoto Y; Matsubara T
    Adv Perit Dial; 2000; 16():108-12. PubMed ID: 11045273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment.
    Próchnicka A; Olszowska A; Baczyński D; Zelichowski G; Wańkowicz Z
    Pol Arch Med Wewn; 2009 Dec; 119(12):815-9. PubMed ID: 20010468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The resurgence of home dialysis therapies.
    Moran J
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):284-9. PubMed ID: 17603983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients.
    Grossekettler L; Schmack B; Brockmann C; Wanninger R; Kreusser MM; Frankenstein L; Kihm LP; Zeier M; Katus HA; Schwenger V; Remppis A
    BMC Nephrol; 2020 May; 21(1):179. PubMed ID: 32410664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrafiltration for decompensated heart failure: renal implications.
    Kazory A; Ross EA
    Heart; 2009 Jul; 95(13):1047-51. PubMed ID: 19261603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of peritoneal dialysis in the treatment of refractory heart failure.
    Kagan A; Rapoport J
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii28-31. PubMed ID: 16024829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrafiltration in the management of acute decompensated heart failure.
    Mielniczuk LM; Haddad H; Davies RA
    Curr Opin Cardiol; 2010 Mar; 25(2):155-60. PubMed ID: 19996964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sustained low-efficiency dialysis (SLED) in patients with prevalent systolic heart failure refractory to medical treatment and with chronic renal failure].
    Iorio L; Violi F; Simonelli R; Nacca RG; Rossi G; Caliendo A; Lamberti F; Mantella D
    G Ital Nefrol; 2006; 23 Suppl 34():S71-3. PubMed ID: 16634000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal ultrafiltration for chronic congestive heart failure: rationale, evidence and future.
    Mehrotra R; Khanna R
    Cardiology; 2001; 96(3-4):177-82. PubMed ID: 11805384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.